Hathal Haddad, Head of Interventional Radiotherapy Unit at the Department of Radiation Oncology at University Hospital Tübingen, shared a post by Igor Tsaur, Director and Chairman of the Department of Urology at the University Hospital Tübingen, on LinkedIn adding:
“Another important milestone for the Urooncolohical Center at Universitätsklinikum Tübingen
With the latest certification for penile cancer by the Deutsche Krebsgesellschaft e. V. (German Cancer Society), Hospital of the university of Tübingen is now a fully certified uro-oncological center covering all major genitourinary cancers:
- Prostate cancer
- Urinary bladder cancer
- Renal cell carcinoma
- Testicular cancer
- Penile cancer
This achievement reflects the outstanding multidisciplinary collaboration and commitment to providing state-of-the-art oncological care for our patients.
Congratulations to Igor Tsaur and the entire uro-oncology team for this excellent achievement and continued dedication to patient care and innovation.”
Quotting Igor Tsaur‘s post:
“Yes, we did it!
After successful certification as a penile cancer center, the scope of our uro-oncology center now includes all major tumor entities of GU oncology:
- Prostate Cancer
- Bladder Cancer
- Renal cell carcinoma
- Testicular Cancer
- Penile Cancer
A big thank you to everyone involved, whose tireless and enthusiastic work made this great milestone possible!”
Other articles featuring Hathal Haddad on OncoDaily.